[ad_1] Glenmark Pharmaceuticals Ltd on Thursday (March 20) said its arms Pharmaceuticals Inc., USA, has received final approval from the US Food & Drug Administration (USFDA) for its Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC). The product has been determined to be bioequivalent to Pataday Once Daily Relief Ophthalmic Solution, 0.2% (OTC), developed by Alcon […]
Glenmark Pharma Q2 Results | Drug firm returns to profit, revenue up 7% – CNBC TV18
[ad_1] Drug firm Glenmark Pharmaceuticals Ltd on Thursday (November 14) reported a net profit of ₹354.4 crore for the second quarter that ended September 30, 2024. In the corresponding quarter of the previous fiscal, Glenmark Pharmaceuticals posted a net loss of ₹180.2 crore, the company said in a regulatory filing. Revenue from operations increased 7.1% […]